- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02949583
Mouthwash of Pomegranate Against Biofilm and Gingival Inflammation in School Children
October 27, 2016 updated by: DANÚBIA ROBERTA DE MEDEIROS NÓBREGA, Universidade Estadual da Paraiba
Clinical Effectiveness and Microbiological Evaluation of a Mouthwash of Pomegranate (Punica Granatum Linn.) in School Children
The mechanical control of supragingival biofilm is accepted as one of the most important measures to prevent dental caries and periodontal diseases.
Nevertheless, maintaining dental surfaces biofilm-free is not an easy task.
In this regard, numerous studies researches have demonstrated the effectiveness of mouthwashes containing antimicrobial active ingredients that prevent and control both supragingival biofilm and gingivitis, specially when used adjunctively to mechanical oral hygiene regimens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In vitro and clinical researches using Punica granatum Linn shows antimicrobial and antiadherent activity against dental biofilm microorganisms.
The purpose of this study was to evaluate the clinical effectiveness of a mouthwash of Punica granatum Linn.
against biofilm and gingival inflammation in school children
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Paraiba
-
Campina Grande, Paraiba, Brazil, 58.429-500
- Universidade Estadual da Paraiba
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age group: 09-12 years old
- Presence of at least 20 teeth
- Simplified Oral Hygiene Index (S-OHI)≥ 1,6
Exclusion Criteria:
- Use of orthodontic appliance
- Recent (in the past 2 months)use of antibiotics and mouthwashes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Punica granatum Linn.
The childrens used the mouthwash contain pomegranate 6,25% twice daily for 14 days.
|
Mouthwash (6,25% of Punica granatum Linn) 10mL per day during 14 days
Other Names:
|
Active Comparator: chlorhexidine
The childrens used the mouthwash contain chlorhexidine 0.12% twice daily for 14 days.
|
standard anti-bacterial mouthwash Mouthwash (0,12% chlorhexidine) 10mL per day during 14 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in the Gingival Index scores.
Time Frame: Baseline, Seventh Day and Fourteeth day (14 days)
|
On day 0, we measured the Plaque Index (PI) (Silness; Löe, 1964) at baseline, on the seventh day and on the fourteenth day.
|
Baseline, Seventh Day and Fourteeth day (14 days)
|
Difference in the Gingival Bleeding Index scores.
Time Frame: Baseline, Seventh Day andFourteeth day (14 days)
|
On day 0, we measured the Bleeding on Probing Index (BPI) (Ainamo; Bay, 1975) at baseline, on the seventh day and on the fourteenth day.
|
Baseline, Seventh Day andFourteeth day (14 days)
|
Difference in the Microbiological analysis of saliva for oral streptococcus count evolution from the start till the end of the study.
Time Frame: Baseline and Fourteeth day (14 days)
|
At baseline, we collected non-stimulated saliva samples into a sterile container for counting of oral streptococci in the laboratory.
And on the fourteenth day, we carried out the second saliva collection and measured the clinical indices used.
|
Baseline and Fourteeth day (14 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: DANÚBIA RM NÓBREGA, Mastering, Universidade Estadual da Paraiba
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Menezes SM, Cordeiro LN, Viana GS. Punica granatum (pomegranate) extract is active against dental plaque. J Herb Pharmacother. 2006;6(2):79-92.
- Bhadbhade SJ, Acharya AB, Rodrigues SV, Thakur SL. The antiplaque efficacy of pomegranate mouthrinse. Quintessence Int. 2011 Jan;42(1):29-36.
- DiSilvestro RA, DiSilvestro DJ, DiSilvestro DJ. Pomegranate extract mouth rinsing effects on saliva measures relevant to gingivitis risk. Phytother Res. 2009 Aug;23(8):1123-7. doi: 10.1002/ptr.2759.
- Vasconcelos LC, Sampaio FC, Sampaio MC, Pereira Mdo S, Higino JS, Peixoto MH. Minimum inhibitory concentration of adherence of Punica granatum Linn (pomegranate) gel against S. mutans, S. mitis and C. albicans. Braz Dent J. 2006;17(3):223-7. doi: 10.1590/s0103-64402006000300009.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
May 20, 2014
First Submitted That Met QC Criteria
October 27, 2016
First Posted (Estimate)
October 31, 2016
Study Record Updates
Last Update Posted (Estimate)
October 31, 2016
Last Update Submitted That Met QC Criteria
October 27, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Effectiveness of Pomegranate
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingivitis
-
Zainab J AbbasCompleted
-
University of SaskatchewanCompletedChronic Gingivitis | Chronic Gingivitis, Plaque InducedCanada
-
Tufts UniversityGuangdong Bixdo Health Technology Co., Ltd.Not yet recruitingPlaque Induced GingivitisUnited States
-
Cairo UniversityNot yet recruiting
-
Hospital Universiti Sains MalaysiaRecruitingGingivitis | Plaque Induced GingivitisMalaysia
-
Lander Enterprises, LLCCompletedPlaque Induced GingivitisUnited States
-
University of WashingtonColgate PalmoliveCompleted
-
Maharishi Markendeswar University (Deemed to be...CompletedChronic GingivitisIndia
-
Kırıkkale UniversityCompletedSmoking | Gingivitis; Chronic
-
University of BaghdadUnknown
Clinical Trials on Punica granatum Linn.
-
Asif AliRecruiting
-
TC Erciyes UniversityEnrolling by invitationPomegranate (P. Granatum) Peel CompressTurkey
-
Horsens HospitalVidens- og Forskningscenter for Alternativ BehandlingCompleted
-
Shiraz University of Medical SciencesCompletedGingivitisIran, Islamic Republic of
-
All India Institute of Medical Sciences, BhubaneswarCompleted
-
Indonesia UniversityNetherlands: Ministry of Health, Welfare and SportsCompleted